Growth Kinetics of Human Mesenchymal Stem Cells in a 3-L Single-Use, Stirred-Tank Bioreactor - The authors describe the growth characteristics of human mesenchymal stem cells cultured in a stirred

ADVERTISEMENT

Growth Kinetics of Human Mesenchymal Stem Cells in a 3-L Single-Use, Stirred-Tank Bioreactor
The authors describe the growth characteristics of human mesenchymal stem cells cultured in a stirred-tank bioreactor.


BioPharm International
Volume 26, Issue 4, pp. 28-38

CONCLUSION

Taken together, these data demonstrate that expansion of hMSCs in 3D culture demonstrate similar flow cytometry profiles, differentiation ability, and functional status as hMSCs expanded in 2D culture. After two weeks, cells reach densities greater than 2105 cells/mL while maintaining their identity as shown by the surface expression of CD105, CD90, and CD73 and the absence of CD14, CD34, and CD45.

The production of well-characterized hMSCs in stirred-tank bioreactors using microcarriers is the first step towards establishing a scalable, single-use production process for the large-scale industrialization of stem cells. The Mobius CellReady 3-L bioreactor presents several advantages compared with multilayer flatbed cultures, including lower overall cost, ease of use, and the ability to closely monitor process parameters through-out expansion and make adjustments while cells are still viable, if needed.

Donghui Jing, PhD*, is a research scientist III, Stem Cell Initiative at EMD Millipore; Neethu Sunil is a research scientist at Experis, Southborough, Mass. Sandhya Punreddy is a research scientist III; Manjula Aysola, PhD, is a research scientist III; Daniel Kehoe, PhD, is a research scientist III; Julie Murrel, PhD, is a senior scientist; Martha Rook, PhD, is head of upstream and sensor technologies; and Knut Niss, PhD, is R&D manager; all at EMD Millipore, Bedford, Mass.

*To whom correspondence should be addressed,

REFERENCES

1. D.J. Prockop, Science 276, 71-74 (1997).

2. M.F. Pittenger and D.R. Marshak, in Stem Cell Biology, D. R. Marshak, R. L. Gardner, and D. Gottlieb, Eds., (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2001).

3. D. Jing et al., Tissue Eng Part B Rev. 14 (4): 393-406 (2008).

4. S.S. Kitambi and Chandrasekar, Stem Cells and Cloning: Advances and Applications 4, 51-59 (2011).

5. J. Rowley et al., BioProcess Intl. 2012 Mar; 10 (S3), 16-22 (2012).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Lundbeck CEO Resigns Due to Code of Conduct Breach
November 24, 2014
GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here